Evidence map›Paper›PMID 36949668›Full record

ArticleBrain and behavior2023

An agile, data-driven approach for target selection in rTMS therapy for anxiety symptoms: Proof of concept and preliminary data for two novel targets.

Isabella M Young, Hugh M Taylor, Peter J Nicholas, Alana Mackenzie, Onur Tanglay, Nicholas B Dadario, Karol Osipowicz, Ethan Davis, Stephane Doyen, Charles Teo and 1 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Brain Connectome for Clinical Neuroscience.Advances in experimental medicine and biology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Isabella M YoungOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Hugh M TaylorOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Peter J NicholasOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Alana MackenzieOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Onur TanglayOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Nicholas B DadarioRutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey.
Karol OsipowiczOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Ethan DavisCingulum Health, Sydney, New South Wales, Australia.
Stephane DoyenOmniscient Neurotechnology, Sydney, New South Wales, Australia.
Charles TeoCingulum Health, Sydney, New South Wales, Australia.
Michael E SughrueOmniscient Neurotechnology, Sydney, New South Wales, Australia.ORCID 0000-0001-5407-2585
Neuroscience Research Australia · AUNew South Wales Department of Health · AURutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionData-driven approaches to transcranial magnetic stimulation (TMS) might yield more consistent and symptom-specific results based on individualized functional connectivity analyses compared to previous traditional approaches due to more precise targeting. We provide a proof of concept for an agile target selection paradigm based on using connectomic methods that can be used to detect patient-specific abnormal functional connectivity, guide treatment aimed at the most abnormal regions, and optimize the rapid development of new hypotheses for future study.

methodsWe used the resting-state functional MRI data of 28 patients with medically refractory generalized anxiety disorder to perform agile target selection based on abnormal functional connectivity patterns between the Default Mode Network (DMN) and Central Executive Network (CEN). The most abnormal areas of connectivity within these regions were selected for subsequent targeted TMS treatment by a machine learning based on an anomalous functional connectivity detection matrix. Areas with mostly hyperconnectivity were stimulated with continuous theta burst stimulation and the converse with intermittent theta burst stimulation. An image-guided accelerated theta burst stimulation paradigm was used for treatment.

resultsAreas 8Av and PGs demonstrated consistent abnormalities, particularly in the left hemisphere. Significant improvements were demonstrated in anxiety symptoms, and few, minor complications were reported (fatigue (n = 2) and headache (n = 1)).

conclusionsOur study suggests that a left-lateralized DMN is likely the primary functional network disturbed in anxiety-related disorders, which can be improved by identifying and targeting abnormal regions with a rapid, data-driven, agile aTBS treatment on an individualized basis.

Indexed as

ConnectomeTranscranial Magnetic StimulationAnxietyAnxiety DisordersHumansMagnetic Resonance ImagingPreliminary Dataanxietybrain stimulationrepetitive transcranial magnetic stimulationtreatment

Identifiers

PMID36949668
PMCPMC10175990
OpenAlexW4360600229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.